Early research (Phase 1)WithdrawnNCT03938922What this trial is testingEvaluate ENT-01 for the Treatment of Parkinson's Disease DementiaWho this might be right forParkinson DiseaseDementia Enterin Inc.
Large-scale testing (Phase 3)Study completedNCT00623103What this trial is testingLong-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)Who this might be right forParkinson's Disease Dementia Novartis 583
Post-approval studies (Phase 4)Study completedNCT00988117What this trial is testingThe Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking ProblemsWho this might be right forParkinsons Disease With DementiaParkinsons Disease With Mild to Moderate Memory and/or Thinking Problems University of California, San Francisco 15
Not applicableStudy completedNCT03687203What this trial is testingCognitive-driven ADL Impairment as a Predictor for PDDWho this might be right forParkinson Disease University Hospital Tuebingen 182
Testing effectiveness (Phase 2)Study completedNCT04764669What this trial is testingE2027 in Participants With Dementia With Lewy Bodies (DLB) or Parkinson's Disease Dementia (PDD) With or Without Amyloid CopathologyWho this might be right forLewy Body DiseaseParkinson Disease Eisai Inc. 34
Testing effectiveness (Phase 2)Study completedNCT02258152What this trial is testingSYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)Who this might be right forParkinson's Disease Dementia (PDD) Biotie Therapies Inc. 82
Not applicableNot Yet RecruitingNCT07114354What this trial is testingEnhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's DiseaseWho this might be right forDementia (Diagnosis)Parkinson Disease Dementia (PDD)Parkinson Disease (PD) The University of Queensland 275
Testing effectiveness (Phase 2)Study completedNCT00630500What this trial is testingEfficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)Who this might be right forDementia Associated With Parkinson's DiseaseDementia With Lewy Bodies Helse Stavanger HF 75
Testing effectiveness (Phase 2)Study completedNCT02708186What this trial is testingStudy Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)Who this might be right forDementia With Lewy BodiesREM Sleep Behavior DisorderParkinson's Disease Dementia Axovant Sciences Ltd. 34